Madison Avenue Partners, LP Gossamer Bio, Inc. Transaction History
Madison Avenue Partners, LP
- $501 Million
- Q1 2024
A detailed history of Madison Avenue Partners, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 4,140,773 shares of GOSS stock, worth $3.73 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
4,140,773
Previous 5,054,472
18.08%
Holding current value
$3.73 Million
Previous $4.6 Million
6.24%
% of portfolio
0.97%
Previous 0.94%
Shares
5 transactions
Others Institutions Holding GOSS
# of Institutions
114Shares Held
190MCall Options Held
405KPut Options Held
490K-
Nea Management Company, LLC Timonium, MD15.8MShares$14.3 Million1.31% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA9.2MShares$8.28 Million0.31% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.27 Million1.7% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $84.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...